PL2308566T3 - Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna - Google Patents

Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna

Info

Publication number
PL2308566T3
PL2308566T3 PL10172755T PL10172755T PL2308566T3 PL 2308566 T3 PL2308566 T3 PL 2308566T3 PL 10172755 T PL10172755 T PL 10172755T PL 10172755 T PL10172755 T PL 10172755T PL 2308566 T3 PL2308566 T3 PL 2308566T3
Authority
PL
Poland
Prior art keywords
orally administered
probiotic bifidobacteria
administered probiotic
beauty benefits
human beauty
Prior art date
Application number
PL10172755T
Other languages
English (en)
Inventor
Amy Violet Trejo
Diamuid O'Mahony Liam
Original Assignee
The Procter And Gamble Company
Alimentary Health Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter And Gamble Company, Alimentary Health Limited filed Critical The Procter And Gamble Company
Publication of PL2308566T3 publication Critical patent/PL2308566T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL10172755T 2005-04-08 2006-04-06 Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna PL2308566T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66962005P 2005-04-08 2005-04-08
EP10172755.0A EP2308566B1 (en) 2005-04-08 2006-04-06 Use of orally administered probiotic bifidobacteria for human beauty benefits

Publications (1)

Publication Number Publication Date
PL2308566T3 true PL2308566T3 (pl) 2017-11-30

Family

ID=36741169

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10172755T PL2308566T3 (pl) 2005-04-08 2006-04-06 Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna

Country Status (8)

Country Link
US (1) US8926952B2 (pl)
EP (2) EP1865795A1 (pl)
JP (1) JP2008535861A (pl)
CN (1) CN101155616A (pl)
AU (1) AU2006235307B2 (pl)
ES (1) ES2640212T3 (pl)
PL (1) PL2308566T3 (pl)
WO (1) WO2006110631A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105796607A (zh) * 2007-02-28 2016-07-27 Mjn 美国控股有限责任公司 用于儿童或婴幼儿的含有灭活益生菌的产品
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
JP2013507394A (ja) * 2009-10-09 2013-03-04 プロセラ インコーポレイテッド 自閉症スペクトル障害と診断されたヒトにおいて自閉症スペクトル障害に関連する少なくとも一つの症状を低減するための、ペディオコッカス属を含む組成物及び方法
FR2953407B1 (fr) * 2009-12-08 2013-06-14 Oreal Microorganismes probiotiques a titre d'actif contre les alterations du microrelief
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3341082B1 (en) 2015-08-27 2020-12-16 PrecisionBiotics Group Limited Bifidobacterium longum
US20180311144A1 (en) * 2015-10-15 2018-11-01 Natura Cosméticos S.A. Cosmetic composition having probiotic bacteria
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
DK3745870T3 (da) * 2018-01-29 2023-02-20 Prec Group Limited Et kombinationsprodukt til profylakse og behandling af irritabel tarmsyndrom
CN112608858A (zh) * 2020-12-17 2021-04-06 上海交大昂立股份有限公司 一种具有祛斑作用的益生菌组合物及其应用
WO2023241390A1 (en) * 2022-06-16 2023-12-21 Nutricia Early Life Nutrition (Shanghai) Co., Ltd. Compositions and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (de) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
FR2756181B1 (fr) * 1996-11-26 1999-03-05 Au Mont Beaute Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US20030092163A1 (en) * 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
UA78547C2 (en) 2002-02-21 2007-04-10 Nestle Sa Light-protective composition for skin intended for oral administration
JP2005526038A (ja) * 2002-02-21 2005-09-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚の光防護のための経口投与可能な組成物
MXPA05008216A (es) * 2003-01-31 2005-10-05 Procter & Gamble Medios para mejorar la apariencia del tejido queratinoso mamifero.
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
WO2005030230A1 (en) * 2003-09-30 2005-04-07 Probiomics Limited Compositions and methods for treatment or prevention of psoriasis and related disorders
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
EP1642570A1 (fr) * 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles

Also Published As

Publication number Publication date
EP1865795A1 (en) 2007-12-19
AU2006235307A1 (en) 2006-10-19
EP2308566A1 (en) 2011-04-13
CN101155616A (zh) 2008-04-02
JP2008535861A (ja) 2008-09-04
ES2640212T3 (es) 2017-11-02
EP2308566B1 (en) 2017-07-05
AU2006235307B2 (en) 2011-07-14
US8926952B2 (en) 2015-01-06
US20070031393A1 (en) 2007-02-08
WO2006110631A1 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
PL2308566T3 (pl) Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL202515A (en) Thyroid-like compounds and their use in the preparation of drugs for the treatment of @ metabolic diseases
SI2069342T1 (sl) Derivati aril fenil imidazo a piridinov njihova priprava in njihova terapevtska uporaba
IL177847A0 (en) Use of lipid conjugates in the treatment of disease
ZA200908928B (en) Formulations for the oral administration of therapeutic agents and related methods
IL212214A0 (en) Use of lipid conjugates in the treatment of disease
ZA201004643B (en) Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
ZA201001207B (en) Therapeutic formulations for the treatment of cold and flu-like symptoms
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
SI1807156T1 (sl) Nove farmacevtske oblike za uporabo pri zdravljenju nespečnosti
ZA201004644B (en) "derivatives of 6-heterocyclic-imidazo[1,2-a]pyrroine-2-carboxamides,preparation thereof and therapeutic application thereof"
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
PL385455A1 (pl) Doustna rozpadająca się farmaceutyczna tabletka preparatów olanzapiny
EP1954800A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1928247A4 (en) COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
PL2106401T3 (pl) Pochodne pirolopirydyno-2-karboksyamidów, ich wytwarzanie i ich zastosowanie w lecznictwie
EP1740541A4 (en) THERAPEUTIC FORMULATIONS OF DESOXYEPOTHILONES
ZA201004641B (en) Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
ZA201004646B (en) Derivatives of n-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides,preparation thereof and therapeutic application thereof
ZA201000582B (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives,preparation and therapeutic use thereof
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases
PL380757A1 (pl) Nowe pochodne epirubicyny, ich nowe zastosowanie medyczne oraz farmaceutycznie akceptowalna postać leku